摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-丁基苯基)-2-氯乙酰胺 | 1527-62-4

中文名称
N-(4-丁基苯基)-2-氯乙酰胺
中文别名
N-(4-丁基苯基)-2-氯-乙酰胺
英文名称
2-chloro-N-(4-butylphenyl)acetamide
英文别名
N-(4-butylphenyl)-2-chloroacetamide
N-(4-丁基苯基)-2-氯乙酰胺化学式
CAS
1527-62-4
化学式
C12H16ClNO
mdl
MFCD01034342
分子量
225.718
InChiKey
NLIULGTVNKLYBM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    130-131 °C
  • 沸点:
    380.5±35.0 °C(Predicted)
  • 密度:
    1.130±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.416
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 海关编码:
    2924299090

SDS

SDS:dbd5583861ed218bdfca4fc7a4f17660
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Narrow SAR in odorant sensing Orco receptor agonists
    摘要:
    The systematic exploration of a series of triazole-based agonists of the cation channel insect odorant receptor is reported. The structure-activity relationships of independent sections of the molecules are examined. Very small changes to the compound structure were found to exert a large impact on compound activity. Optimal substitutions were combined using a 'mix-and-match' strategy to produce best-in-class compounds that are capable of potently agonizing odorant receptor activity and may form the basis for the identification of a new mode of insect behavior modification. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2014.04.081
  • 作为产物:
    描述:
    参考文献:
    名称:
    巯基甲基乙酸巯基乙酸酯硫醚:一种用于开发L1金属-β-内酰胺酶抑制剂的新型支架。
    摘要:
    考虑到金属β-内酰胺酶(MβLs)的临床重要性,构建了一种新的支架,N-取代的氨基甲酰基巯基乙酸乙酸酯硫醚。所获得的分子1-16抑制所有三个亚类的MβLs,但优先抑制来自B3亚类的L1。具有p-羧苯基取代基的化合物9表现出最宽的光谱,对100μM的所有亚类的酶均具有至少70%的抑制作用,而具有p-甲基苯基取代基的化合物5是任何单个酶中最有效的抑制剂,具有97%的抑制作用100μM时对L1的IC50值为0.41μM。等温滴定量热法测定法证实了紫外可见分光光度法测定的结果,即5对L1的抑制作用是剂量依赖性的。对接研究表明,羧基,硫化物原子,氨基甲酰基的羰基以螯合方式与Zn2配位。使用表达L1、6和8的大肠杆菌细胞能够将头孢唑林的最小抑制浓度降低8倍。
    DOI:
    10.1021/acsmedchemlett.7b00058
点击查看最新优质反应信息

文献信息

  • An Old Story in the Parallel Synthesis World: An Approach to Hydantoin Libraries
    作者:Andrey V. Bogolubsky、Yurii S. Moroz、Olena Savych、Sergey Pipko、Angelika Konovets、Maxim O. Platonov、Oleksandr V. Vasylchenko、Vasyl V. Hurmach、Oleksandr O. Grygorenko
    DOI:10.1021/acscombsci.7b00163
    日期:2018.1.8
    An approach to the parallel synthesis of hydantoin libraries by reaction of in situ generated 2,2,2-trifluoroethylcarbamates and α-amino esters was developed. To demonstrate utility of the method, a library of 1158 hydantoins designed according to the lead-likeness criteria (MW 200–350, cLogP 1–3) was prepared. The success rate of the method was analyzed as a function of physicochemical parameters
    开发了一种通过原位生成的2,2,2-三氟乙基氨基甲酸酯与α-氨基酯反应平行合成乙内酰脲文库的方法。为了证明该方法的实用性,准备了根据铅样标准(MW 200–350,cLogP 1-3)设计的1158个乙内酰脲文库。分析了该方法的成功率与产品理化参数的关系,发现该方法可以被认为是用于铅导向合成的工具。通过合理设计,使用开发的方法进行平行合成,计算机模拟和体外筛选相结合的方法,发现了一种含乙内酰脲的超微摩尔主要分子,可作为Aurora激酶A抑制剂。
  • Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors
    作者:Le Zhai、Yi-Lin Zhang、Joon S. Kang、Peter Oelschlaeger、Lin Xiao、Sha-Sha Nie、Ke-Wu Yang
    DOI:10.1021/acsmedchemlett.5b00495
    日期:2016.4.14
    against CcrA, ImiS, and L1 at inhibitor concentrations of up to 10 μM. Compounds 4d and 6c are partially mixed inhibitors with Ki values of 0.49 and 0.63 μM using cefazolin as the substrate. Structure–activity relationship studies reveal that replacement of hydrogen on the aromatic ring by chlorine, heteroatoms, or alkyl groups can affect bioactivity, while leaving the aromatic ring of the triazolylthiols
    金属β-内酰胺酶(MβLs)裂解β-内酰胺抗生素的β-内酰胺环,赋予这些药物对细菌的抗性。制备了二十四种三唑基硫代乙酰胺,并将其评估为代表MβLs三种亚类的抑制剂。所有这些化合物均显示出对NDM-1的特异性抑制活性,IC 50值范围为0.15-1.90μM,但在抑制剂浓度高达10μM时对CcrA,ImiS和L1无活性。化合物4d和6c是与K i部分混合的抑制剂以头孢唑林为底物时的0.49和0.63μM值。结构与活性之间的关系研究表明,用氯,杂原子或烷基取代芳环上的氢会影响生物活性,而使三唑基硫醇的芳环保持未修饰状态则可保持抑制作用。对接研究表明,典型的强效NDM- 1、4d和6c抑制剂在NDM-1的活性位点形成稳定的相互作用,三唑桥接Zn1和Zn2,酰胺与Lys 211(Lys224)相互作用。
  • Cardioselective aryloxy- and arylthio-hydroxypropyl piperazinyl acetanilides wich affect calcium entry
    申请人:SYNTEX (U.S.A.) INC.
    公开号:EP0126449A1
    公开(公告)日:1984-11-28
    Novel compounds of the general formula and the pharmaceutically acceptable esters and acid addition salts thereof, wherein: R1, R2, R3, R4, and R5 are each independently hydrogen, lower alkyl, lower alkoxy, cyano, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, N-optionally substituted alkylamido, except that when R1 is methyl, R4 is not methyl; or R2 and R3 together form -OCH2O-; R6, R7, R8, R9 and R10 are each independently hydrogen, lower acyl, aminocarbonyl-methyl, arylcyano, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, di-lower alkyl amino; or R6 and R7 together form -CH = CH-CH = CH-; R7 and R8 together form -OCH2O -; R11 and R12 are each independently hydrogen or lower alkyl; and W is oxygen or sulfur. These cardioselective compounds have calcium entry blockade properties and therefore are useful in therapy in the treatment of cardiovascular diseases, including arrhythmias, variant and exercise induced angina and myocardial infarction.
    通式为 及其药学上可接受的酯和酸加成盐,其中 R1、R2、R3、R4 和 R5 各自独立地为氢、低级烷基、低级烷氧基、氰基、三氟甲基、卤代、低级烷硫基、低级烷基亚磺酰基、低级烷基磺酰基、N-可选取代的烷基氨基,但当 R1 为甲基时,R4 不是甲基;或 R2 和 R3 共同形成 -OCH2O-; R6、R7、R8、R9 和 R10 各自独立地为氢、低级酰基、氨基羰基甲基、芳基氰基、低级烷基、低级烷氧基、三氟甲基、卤代、低级烷硫基、低级烷基亚磺酰基、低级烷基磺酰基、二低级烷基氨基;或 R6 和 R7 共同形成 -CH = CH-CH = CH-; R7 和 R8 共同形成 -OCH2O -; R11 和 R12 各自独立地为氢或低级烷基;以及 W 是氧或硫。 这些心脏选择性化合物具有钙离子进入阻断特性,因此可用于治疗心血管疾病,包括心律失常、变异型和运动诱发的心绞痛和心肌梗塞。
  • Discovery of novel AHLs as potent antiproliferative agents
    作者:Jing-Li Ren、Xu-Yao Zhang、Bin Yu、Xi-Xin Wang、Kun-Peng Shao、Xiao-Ge Zhu、Hong-Min Liu
    DOI:10.1016/j.ejmech.2015.02.026
    日期:2015.3
    Three series of novel AHL analogs were synthesized and evaluated for their in vitro cytotoxic activity against four human cancer cell lines. The SARs investigation indicated that AHLs with a terminal phenyl group, especially those with the chalcone scaffold had remarkably enhanced cytotoxicity than those with the hydrophobic side chains. Besides, some of these compounds were much more potent than 5-Fu and natural OdDHL. Through the detailed SARs discussions, we found that compounds 10a-k and 14 with the 4-amino chalcone scaffold showed excellent inhibition against all the tested cancer cell lines and were much more potent than 5-Fu and AHLs. Such scaffold may act as a template for further lead optimization. Compound 10i with a 3, 4, 5-trimethoxy group was the most potent one against all the tested cancer cell lines. Flow cytometry analysis indicated that analog lie induced the cellular apoptosis and cell cycle arrest of MCF-7 cells at G2/M phase in a concentration-and time-dependent manner. (C) 2015 Elsevier Masson SAS. All rights reserved.
  • Inhibitors of Tick-Borne Flavivirus Reproduction from Structure-Based Virtual Screening
    作者:Dmitry I. Osolodkin、Liubov I. Kozlovskaya、Evgenia V. Dueva、Victor V. Dotsenko、Yulia V. Rogova、Konstantin A. Frolov、Sergey G. Krivokolysko、Ekaterina G. Romanova、Alexey S. Morozov、Galina G. Karganova、Vladimir A. Palyulin、Vladimir M. Pentkovski、Nikolay S. Zefirov
    DOI:10.1021/ml400226s
    日期:2013.9.12
    Flaviviruses form a large family of enveloped viruses affecting millions of people over the world. To date, no specific therapy was suggested for the infected people, making the treatment exclusively symptomatic. Several attempts were performed earlier for the design of fusion inhibitors for mosquito-borne flaviviruses, whereas for the tick-borne flaviviruses such design had not been performed. We have constructed homology models of envelope glycoproteins of tick-transmitted flaviviruses with the detergent binding pocket in the open state. Molecular docking of substituted 1,4-dihydropyridines and pyrido[2,1-b][1,3,5]-thiadiazines was made against these models, and 89 hits were selected for the in vitro experimental evaluation. Seventeen compounds showed significant inhibition against tick-borne encephalitis virus, Powassan virus, or Omsk hemorrhagic fever virus in the 50% plaque reduction test in PEK. cells. These compounds identified through rational design are the first ones possessing reproduction inhibition activity against tick-borne flaviviruses.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐